Clinical Trial Update: Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients

View source ↗

Summary

This clinical trial update describes how the immune system responds to tocilizumab treatment in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Rheumatoid Arthritis | Status: COMPLETED